@OpenAI: GPT-5.6 is a major step forward for health intelligence. Across the lineup, we’re delivering stronger performance at lo…
Summary
OpenAI announces GPT-5.6, a major step forward for health intelligence with stronger performance and 25x lower cost for GPT-5.6 Luna compared to GPT-5.5, making advanced models more accessible globally.
View Cached Full Text
Cached at: 07/10/26, 10:15 PM
GPT-5.6 is a major step forward for health intelligence.
Across the lineup, we’re delivering stronger performance at lower cost: GPT-5.6 Luna outperforms GPT-5.5 at its highest reasoning setting while costing 25x less.
Together, these advances raise quality while making advanced models accessible to more people globally.
Similar Articles
@OpenAI: We are committed to pushing the model frontier across cost efficiency, capability, and speed. Starting today, we are re…
OpenAI has reduced prices for GPT-5.6 Luna by 80% and GPT-5.6 Terra by 20%, and introduced a faster option for GPT-5.6 Sol in the API, while also adjusting usage counting in Codex and ChatGPT Work.
Advancing the price-performance frontier with GPT‑5.6
OpenAI announces significant price reductions for GPT-5.6 Luna (80% less) and Terra (20% less), and introduces Fast mode for GPT-5.6 Sol with up to 2.5x faster speeds in the API, aiming to improve cost-efficiency for customers.
OpenAI launches its new family of models with GPT-5.6
OpenAI launched GPT-5.6, a family of three models (Sol, Terra, Luna) with improved efficiency, cybersecurity capabilities, and competitive pricing, aimed at enterprise and coding tasks.
How GPT-5.6 fuses frontier intelligence with frontier efficiency
OpenAI announces the GPT-5.6 model family, including Sol, Terra, and Luna, which achieve frontier intelligence with significantly improved efficiency and cost reductions, backed by innovations in inference and agentic harness.
OpenAI unveils GPT-5.6 amid US AI regulatory drama
OpenAI has unveiled GPT-5.6, a new model suite featuring Sol, Terra, and Luna, with improved performance in coding, cybersecurity, and agentic tasks, amid heightened US regulatory scrutiny.